Association of smoking and smoking cessation with major causes of mortality in the Asia Pacific Region: the Asia Pacific Cohort Studies Collaboration
In the West, smoking has long been known to be a major cause of death and disability and has been estimated to kill one out of two smokers prematurely. 1 Similarly, in Western populations, the benefits associated with quitting smoking have been clearly demonstrated and in general, are widely accepted by smokers and non-smokers. [1] [2] [3] The vast majority of Westerners who currently smoke are aware that smoking increases their subsequent risk of cancer, cardiovascular disease and respiratory illnesses. Consequently, a significant proportion of smokers want, or have tried, to quit the habit. Over the past three decades, most developed countries have been successful in implementing comprehensive anti-tobacco measures that have resulted in substantial reductions in the prevalence of smoking such that the number of former smokers in countries such as the UK and Australia now exceeds that of current smokers. 4 Across large parts of Asia the situation is the reverse and an estimated 50-70% of adult men are reported to be current smokers. 5 In most Asian countries smoking cessation is a relatively infrequent event; a likely consequence of the wide cultural acceptance that smoking continues to enjoy in the region (particularly among men). 4 6 7 For example, data from the China National Prevalence Survey (1996) showed the prevalence of former smokers to be only 10%, and that the most common reason for quitting was ill health. Further, 60% of Chinese smokers have never contemplated quitting. 6 Raising public awareness in Asia as to the health consequences caused by smoking is a vital first step in implementing effective tobacco control strategies and potentially would go some way towards reversing its cultural acceptability. However, only a small fraction of the studies that have reported on the associations between smoking and mortality have been conducted in these countries. Therefore, the objective of this current study is to provide reliable evidence as to the impact of smoking, and the likely benefits associated with quitting the habit, on total mortality and major causes of mortality among populations of the Asia Pacific region using data from the Asia Pacific Cohort Studies Collaboration (APCSC). 8 
METHODS
Details of study identification, data collection and event verification in the APCSC are described elsewhere. 8 Briefly, studies were included if they had continued follow-up for at least 5000 personyears and had recorded vital status at the end of follow-up. Studies were excluded if entry was dependent upon a particular condition or risk factor. Mortality was classified according to the 9th Revision of the International Classification of Diseases (ICD). The outcomes investigated in this analysis were all causes of death, cancer, cardiovascular disease, respiratory disease (ICD9: 490 Analyses were based on individual participant data and restricted to participants over 20 years of age. All data on cigarette smoking were based on self-report at the time of entry into one of the included studies. This analysis comprises studies that recorded whether individuals were current, former or never smokers; participants were grouped as ''current'' if they smoked currently, ''never smokers'' if they had never smoked and ''former smokers (or ex-smokers)'' if they had smoked in the past but reported having already quit at the time of entry. For those studies collecting information on the amount of cigarettes smoked per day (CPD), current smokers were classified in three approximately equal sized groups: ,20, 20 and .20 CPD; 20 cigarettes corresponds to one standard pack.
Cox proportional hazard models, adjusted for age and stratified by study, were used to derive the hazard ratios and corresponding 95% CIs for death for ''ex-smokers'' as compared with ''current'' smokers and for ''current'' as compared with ''never smoked''. Since the effect of quitting on the reduction of mortality risk might have been underestimated due to participants stopping smoking because of health-related issues, a sensitivity analysis was also performed in which the first 3 years of follow-up were excluded. Hazard ratios for doseresponse of CPD were estimated using ''never smoked'' as the reference group. Confidence intervals were calculated using the method of floating absolute risks. 9 Region-and sex-specific results were derived and heterogeneity of the estimated hazard ratios between groups was investigated through fitting interaction terms for region by smoking and sex by smoking. Heterogeneity of the estimated hazard ratios between three at risk age groups (,65, 65-74, >75) was assessed using a x 2 test.
RESULTS

Baseline characteristics and mortality data
Of the 44 studies in APCSC, 34 (25 in Asia) provided data on current smoking status that distinguished former from never smokers. A total of 22 studies provided data on cigarette consumption for current smokers (table 1) . Overall, information on 512 676 participants (81% from Asia) were included in the analyses.
Smoking habits varied by region and by sex. At baseline, in ANZ, 14% of women and 20% of men declared themselves as current smokers, and 21% and 43% of women and men, respectively, were reported as having quit smoking. In Asia, 59% of men were current smokers and 11% were former smokers; the corresponding figures in women were 3% and 0.9%. Female and male smokers in ANZ and male smokers in Asia had the same mean CPD (14) ; Asian women smoked, on average, 9 CPD.
In ANZ, during a median follow-up of 8.3 years, 3241 women and 5831 men died (table 2). In both sexes, cardiovascular disease was the leading cause of death (40%), followed closely by cancer, (35%). Approximately 7% of deaths were due to respiratory disease and 4% to injury. In Asia, over a median follow-up of 5.6 years a total of 3334 women and 8398 men died. The most common cause of death in men was cancer (38%) and in women cardiovascular disease (40%). Injury fatalities were more common in Asian men and women (10% and 6%, respectively) compared with participants from ANZ.
The age-adjusted mortality rates for all-cause mortality were systematically higher among current smokers compared with never smokers (table 2). In general, in ANZ mortality rates among former smokers were higher, or similar, to those of never smokers whilst in Asia they were higher or similar to those of current-smokers in Asia. The rates differences indicated a greater absolute effect of smoking on mortality risk in ANZ compared with Asia. For example, for all causes mortality the rates difference between current smokers and never smokers was equal to 80.1 and 48.8 per 10 000 person years in ANZ men and women respectively. The corresponding figures in Asia were 22.9 and 31.2 per 10 000 person-years.
Hazard ratios for smoking-related mortality
In ANZ, age-adjusted hazard ratios for current smokers, as compared with never smokers, showed a significant excess risk for all the outcomes except for injury mortality in women (table 3) . There was no evidence of heterogeneity between sexes for any of the outcomes (range of p values for interaction: 0.41-0.59). Compared with never smokers, current smokers had risks of mortality from all-site cancer and respiratory illness that were approximately two and five times higher, respectively; mortality from cardiovascular disease was also 60 to 80% higher among current smokers compared with never smokers. Smoking was associated with a smaller increase in risk, of about 50% and 30%, for injury and other causes respectively.
In Asia, associations were less strong than those in ANZ for cancer, cardiovascular, respiratory and all-cause mortality (all p values for regional interaction ,0.001). Similar to ANZ, there were no evidence of any sex difference in the magnitude of the associations for any of the outcomes (p value for sex interaction: 0.43-0.96). Current smokers had a 61% (95% CI 29 to 100) greater risk of cancer in women and 44% (95% CI 32 to 57) in men. In both sexes, cardiovascular mortality risk increased by more than 40%, all-cause mortality by about one-third, and respiratory risk by about one-quarter.
There was a strong log-linear association between the number of cigarettes smoked per day and the risk of total mortality in both regions and in both sexes (all p values for linear trend ,0.001; fig 1) . The dose response relationship was stronger in ANZ than in Asia (p value for region interaction for men ,0.001, for women = 0.014). For example, comparing those who smoked 20 or more cigarettes per day to never smokers, the hazard ratio and 95% CI for all-cause mortality was 1.52 (1.36 to 1.70) and 1.30 (0.32 to 5.19) in men and women in Asia and 2.59 (2.32 to 2.89) and 2.94 (2.42 to 3.57) in men and women in ANZ. In Asia and ANZ there was no indication of a sex interaction (p value for interaction >0.23).
Hazard ratios for mortality among former smokers
In ANZ, mortality risks were significantly reduced in former smokers as compared with current smokers for all the outcomes, with the exception of ''other causes'' in both sexes and injury in women. The risk of all-cause mortality was reduced by about one-third and similar reductions were estimated for the risk of cancer and cardiovascular disease; the risk of respiratory death was reduced by about two-thirds; and that of injury by 45% in men.
In Asia, there were no significant differences in most hazard ratios comparing former smokers with current smokers. The hazard ratio for all-cause mortality comparing former with current smokers was 0.98 (0.92, 1.05) in men and 1.03 (0.86, 1.24) in women. When the data were left-censored to exclude deaths during the first 3 years of follow-up, the hazard ratios comparing former with current smokers in males from Asia were 0.88 (0.81, 0.97) for all-cause mortality and 0.82 (0.70-0.96) for cancer. Similarly the HRs were decreased but remained non significant, for cardiovascular and for mortality from other causes (table 3) . By contrast, the hazard ratio for respiratory mortality was significantly increased in former versus current 
Age specific hazard ratios
Smoking was associated with a significant increased risk of allcause mortality at all ages but it had a relatively stronger impact among individuals at risk at ''younger'' ages in ANZ and Asia (p values for age interaction ,0.001 in ANZ and 0.007 in Asia; table 4). In both regions the hazard ratio for all-cause mortality among current smokers was significantly higher among individuals less than 65 years of age compared with those aged over 75 years (p value for interaction ,0.001). The benefits derived from quitting smoking were significant at all ages in ANZ, being greater among younger individuals who presumably would have been smoking for fewer years and had quit at younger age. From the youngest to the oldest age at risk group, quitting appeared to decrease the risk of mortality in ANZ, respectively by 43, 37 and 24% (p value for age interaction ,0.001). In Asia, where the effect of quitting smoking was less clear, only those in the youngest age group who had quit had a significant 10% reduction in the risk of all-cause mortality compared with continuing smokers.
CONCLUSIONS
Our findings, based on data from over half a million individuals, show that cigarette smoking is associated with a significant increase in the risk of cancer, cardiovascular disease and anycause mortality, for both sexes in Asian and Caucasian populations of the Asia Pacific region. Smoking is also a significant risk factor for fatal respiratory disease and deaths from ''other causes'' except in the case of Asian women, among whom smoking is rare. Furthermore, there was evidence of a positive association of smoking with death from injury in cohorts from ANZ. The excess risks of mortality from all causes were apparent at all ages but were consistently greater among younger individuals in Asia and ANZ. For all-cause mortality the excess risks associated with smoking were significantly higher in ANZ compared with Asia. Current smokers in ANZ had twice the risk compared with never smokers, whereas in Asia, current smokers had a one-third higher risk. The magnitude of these estimates, as well as the smaller observed effect among Asian cohorts, are consistent with previous findings from studies conducted in Australia, 10 New Zealand 11 and Europe 1 12-14 China, [15] [16] [17] [18] Taiwan, 19 20 Japan [21] [22] [23] and Korea. 24 Although the relative risks associated with smoking were generally lower in Asia compared with ANZ, particularly for women, this is likely to reflect reported differences in the maturity of the smoking epidemic across the region 5 25-28 rather than it being indicative of any physiological, or genetic, differences between Asians and non-Asians. 29 A shorter length of study follow up among the Asian cohorts may also have underestimated the effects, given that the risks of smoking are determined not only by the amount smoked and the age at which smoking commences, but also by the duration of smoking. Consequently, the full impact of smoking on health in the region has yet to be realised and is unlikely to be apparent for at least another decade.
Differences in the reasons for quitting may also account for some of the variation in the impact of smoking between the regions. In China, most former smokers quit due to an already established illness, 6 by which time, stopping smoking would have little effect on altering disease progression; hence such patterns of smoking cessation are associated with only modest reductions in relative risk or in some instances, an actual increase in the risk (due to the problem of reverse causality).
Although our analyses did not adjust for education or socio economic status or personality, variables that were not collected in the APCSC, our finding of a positive association between smoking and mortality from injury in cohorts from ANZ is consistent with findings from a meta-analysis of four studies from the USA and Northern Europe. 30 In that meta-analysis, a dose-response relationship between smoking and injuries was observed, and this persisted after adjustment for alcohol consumption and socioeconomic status. It has been suggested that the apparent association between smoking and injury might be confounded by personality type; individuals who smoke are postulated to engage in risky behaviours resulting in an increased propensity towards incurring an injury. 31 Studies have also shown that people with mental illness are about twice as likely to smoke as others. 32 33 Thus, whether the relationship is causal or due to confounding remains a matter of ongoing debate and for investigation by future studies.
Importantly, findings from the current study demonstrate the effectiveness of quitting smoking on reducing the risk of mortality across all populations in the Asia Pacific region, although the benefits tended to be greater for former smokers in cohorts from ANZ compared with those from Asia. In ANZ, quitting smoking was associated with a reduction of 30% in the risk of all-cause mortality compared with one of about a 10% among male former smokers in Asia. The benefits of quitting smoking were also greater among younger individuals (,65 years) presumably because they have smoked for fewer years compared with older individuals, and older individuals often quit too late after having serious illnesses.
We found an increased risk of 37% in respiratory mortality in former versus current smokers. This is likely due to reverse causality and is consistent with the increased risk of chronic Figure 1 Hazard ratios for all-cause mortality by number of cigarettes per day (base = never smokers), by region and sex. Lines show 95% CIs. ANZ, Australians and New Zealanders. obstructive pulmonary disease in former smokers in a cohort study of Chinese retired men 18 and similar findings for deaths due to respiratory disease in Taiwan. 19 We attempted to remove the potential for reverse causality by eliminating the first 3 years of follow-up, the overall effect of which was a general lowering of the risks among male former smokers in Asia (with the exception of respiratory illness). By comparison, left-censoring had no impact in ANZ, which lends support to the aforementioned idea that individuals in Asia are more likely to quit smoking due to reasons of ill health.
The current analyses are limited by the lack of information on the duration and age at which smoking commenced, both of which are more important determinants of subsequent risk than the actual amount smoked. 34 Related to this, we also lacked data on the time since quitting smoking and consequently, we were unable to examine how risk may have evolved over time among former-smokers. Furthermore, APCSC analyses were based on self-reported cigarette consumption at baseline, and information on change in smoking habits during follow-up was available from too few studies to enable any meaningful analysis to be undertaken. Finally, the individual studies used different methods to verify cause of death, which would have resulted in an underestimation of the risks associated with smoking. Moreover, these methods will have varied over time and the lack of standardisation could have had some unpredictable effect on the results.
Currently, interventions that only focus on preventing people from starting to smoke will do little to prevent an estimated 1 billion deaths due to smoking by the end of the 21st century, 100 million of which will occur in China alone. 4 A low level of awareness as to the harmful effects of cigarette smoking and of the health and economic benefits associated with quitting, 35 the mistaken belief that quitting could be harmful to some chronic smokers, combined with a lack of comprehensive tobacco control programmes, 6 may explain much of the ongoing popularity of smoking in China and other Asian countries. Effective tobacco control strategies and implementation of smoke-free policies 36 are urgently needed across Asia in order to assist many smokers to quit and thus to prevent the large number of deaths that are predicted to occur if current smoking patterns persist. 27 
